AstraZeneca’s lupus drug fails to meet main goal in study
AstraZeneca's anifrolumab, which is given intravenously, was being developed for lupus, a chronic autoimmune disease with limited…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.